Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Champions Oncology, Inc. - Common Stock
(NQ:
CSBR
)
9.260
+0.370 (+4.16%)
Streaming Delayed Price
Updated: 12:04 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Champions Oncology, Inc. - Common Stock
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
December 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 14, 2022
Via
Benzinga
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
December 13, 2022
Via
ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
December 09, 2022
Via
ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
September 08, 2022
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Via
ACCESSWIRE
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
September 16, 2022
Gainers
Via
Benzinga
Earnings Scheduled For September 8, 2022
September 08, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its second quarter. • Sono Group (NASDAQ:SEV) is estimated to report earnings for its second...
Via
Benzinga
Earnings Preview For Champions Oncology
September 07, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022
September 06, 2022
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Record Annual Revenue of $49.1 Million
From
Champions Oncology, Inc.
Via
AccessWire
A Preview Of Champions Oncology's Earnings
July 20, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
July 14, 2022
HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Earnings Scheduled For July 21, 2022
July 21, 2022
Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion.
Via
Benzinga
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
May 31, 2022
HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here's How Much You Would Have Made Owning Champions Oncology Stock In The Last 5 Years
March 21, 2022
Champions Oncology (NASDAQ:CSBR) has outperformed the market over the past 5 years by 7.88% on an annualized basis. Buying $1,000 In CSBR: 5 years ago, an investor could have...
Via
Benzinga
Champions Oncology Earnings Perspective: Return On Capital Employed
March 16, 2022
According to Benzinga Pro, during Q3, Champions Oncology (NASDAQ:CSBR) earned $787.00 thousand, a 184.12% increase from the preceding quarter. Champions Oncology also posted a...
Via
Benzinga
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million
March 15, 2022
HACKENSACK, NJ / ACCESSWIRE / March 15, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Earnings Scheduled For March 15, 2022
March 15, 2022
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...
Via
Benzinga
Earnings Preview For Champions Oncology
March 14, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022
March 11, 2022
HACKENSACK, NJ / ACCESSWIRE / March 11, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
February 15, 2022
HACKENSACK, NJ / ACCESSWIRE / February 15, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates
January 20, 2022
HACKENSACK, NJ / ACCESSWIRE / January 20, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs
January 04, 2022
HACKENSACK, NJ / ACCESSWIRE / January 4, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative pharmacology,...
From
Champions Oncology, Inc.
Via
AccessWire
Looking Into Champions Oncology's Return On Capital Employed
December 14, 2021
According to Benzinga Pro, during Q2, Champions Oncology (NASDAQ:CSBR) earned $277.00 thousand, a 261.05% increase from the preceding quarter. Champions Oncology also posted a...
Via
Benzinga
Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
December 13, 2021
Reported income from operations of $263,000 HACKENSACK, NJ / ACCESSWIRE / December 13, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming...
From
Champions Oncology, Inc.
Via
AccessWire
Earnings Scheduled For December 13, 2021
December 13, 2021
Companies Reporting Before The Bell • Qudian (NYSE:QD) is projected to report quarterly earnings at $0.18 per share on revenue of $56.15 million. Companies...
Via
Benzinga
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
December 06, 2021
HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug discovery and development will report...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus
October 20, 2021
HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned...
From
Champions Oncology, Inc.
Via
AccessWire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.